AIGH Capital Management’s NLS Pharmaceutics Warrant NLSPW Stock Holding History

AIGH Capital Management’s Portfolio NLSPW Stock Details NLSPW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-826,921	Closed	-$240K	–	58
2022 Q4	$240K	Buy	826,921 +632,861	+326%	+$112K	0.08%	46
2022 Q3	$49K	Sell	194,060 -633,361	-77%	-$130K	0.02%	49
2022 Q2	$99K	Sell	827,421 -500	-0.1%	-$121	0.03%	45
2022 Q1	$1.17M	Hold	827,921	–	–	0.29%	37
2021 Q4	$919K	Hold	827,921	–	–	0.28%	45
2021 Q3	$2.07M	Hold	827,921	–	–	0.44%	43
2021 Q2	$872K	Buy	+827,921	New	+$734K	0.16%	45

Other funds holding NLSPW

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

ACM

Altium Capital Management New York $42M AUM

Ayrton Capital Westport, Connecticut $14.7M AUM 12.82% 1-Year Est. Return

Hudson Bay Capital Management Stamford, Connecticut $29B AUM 30.2% 1-Year Est. Return

Clear Street New York $24.6B AUM 56.25% 1-Year Est. Return

AIGH Capital Management's NLSPW Position: Q4 2022 in Review

AIGH Capital Management sold out of NLS Pharmaceutics Warrant (NLSPW) in Q4 2022, closing a stake of 633,361 shares — an estimated $112K sold.

AIGH Capital Management first reported a position in NLSPW in Q3 2022 and held it in 1 quarter. The position peaked at $158K in Q3 2022. 5 funds tracked by Wall St. Rank hold NLSPW as of Q4 2022.

AIGH Capital Management reported no remaining NLS Pharmaceutics Warrant position as of Q4 2022 after selling out during the quarter.
AIGH Capital Management sold 633,361 NLS Pharmaceutics Warrant shares in Q4 2022, an estimated $112K.
AIGH Capital Management first reported a position in NLS Pharmaceutics Warrant in Q3 2022 and held it in 1 quarter.
AIGH Capital Management's NLS Pharmaceutics Warrant position peaked at $158K in Q3 2022.
5 funds tracked by Wall St. Rank held NLS Pharmaceutics Warrant as of Q4 2022.

Based on AIGH Capital Management's 13F filing for Q4 2022, filed 15 Feb 2023.